Fetal nasal bone as ultrasonographic marker for trisomy 21 in a low-risk population between 18 and 22 gestational weeks

By Gámez F.   Ferreiro P.  

The Ultrasound Review of Obstetrics & Gynecology, Vol. 5, Iss. 3, 2005-09 ,pp. : 171-177

Informa Healthcare

Access to resources Recommend Favorite

Maternal serum markers for fetal trisomy 21 screening

By Muller F.   Bussieres L.  

European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol. 65, Iss. 1, 1996-03 ,pp. : 3-6

Elsevier

Access to resources Recommend Favorite

Do amniotic fluid leptin levels decrease in pregnancies with fetal trisomy 21?

By Demir A.   Saatli B.   Cagliyan E.   Solak A.   Guclu S.  

Journal of Obstetrics & Gynaecology, Vol. 32, Iss. 6, 2012-08 ,pp. : 540-542

Informa Healthcare

Access to resources Recommend Favorite

Pre-eclampsia and trisomy 13

By Heydanus R.   Defoort P.   Dhont M.  

European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol. 60, Iss. 2, 1995-06 ,pp. : 201-202

Elsevier

Access to resources Recommend Favorite

The fetal fraction of cell-free DNA in maternal plasma is not affected by a priori risk of fetal trisomy

By Brar Herb   Wang Eric   Struble Craig   Musci Thomas J.   Norton Mary E.  

Journal of Maternal-Fetal and Neonatal Medicine, Vol. 26, Iss. 2, 2013-01 ,pp. : 143-145

Informa Healthcare

Access to resources Recommend Favorite